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Background: Lipoxygenases (LOX) catalyze the oxygenation of polyunsaturated fatty acids but generate distinct products
from a common substrate.
Results: We report the first structure of a LOX-substrate complex.
Conclusion: The structure provides a context for understanding product specificity in enzymes that metabolize arachidonic
acid.
Significance: With roles in the production of potent lipid mediators, LOX are targets for drug design.
Lipoxygenases (LOX) play critical roles in mammalian
biology in the generation of potent lipid mediators of the inflam-
matory response; consequently, they are targets for the develop-
ment of isoform-specific inhibitors. The regio- and stereo-spec-
ificity of the oxygenation of polyunsaturated fatty acids by the
enzymes is understood in terms of the chemistry, but structural
observation of the enzyme-substrate interactions is lacking.
Although several LOX crystal structures are available, hereto-
fore the rapid oxygenation of bound substrate has precluded
capture of the enzyme-substrate complex, leaving a gap between
chemical and structural insights. In this report, we describe the
2.0 Å resolution structure of 8R-LOX in complex with arachi-
donic acid obtained under anaerobic conditions. Subtle rear-
rangements, primarily in the side chains of three amino acids,
allow binding of arachidonic acid in a catalytically competent
conformation. Accompanying experimental work supports a
model in which both substrate tethering and cavity depth con-
tribute to positioning the appropriate carbon at the catalytic
machinery.
Lipoxygenases (LOX)2 catalyze the highly regio- and stereo-
specific reaction of polyunsaturated fatty acids with molecular
oxygen, typically forming a single, chiral fatty acid hydroperox-
ide (1–3). The diversity is such that individual LOX enzymes
are known that can account for oxygenation on almost all the
available positions on the common polyunsaturated fatty acid
substrates (3–5). The different members of the LOX superfam-
ily, whether prokaryotic, plant, fungal, invertebrate, or verte-
brate/mammalian, all retain the same conserved amino acids at
the catalytic center and share a common structural framework
(6 –12). Taken together with an in-depth understanding of the
basic chemistry involved in LOX catalysis (4, 13–15), this sim-
ilarity has led to models in which much of the diversity in prod-
uct formation is accounted for by proposed differences in sub-
strate binding (Fig. 1) and by the direction of oxygen attack on
the activated fatty acid. Two variables in fatty acid binding can
influence the product outcome. 1) Polyunsaturated fatty acids
may have one or more pentadienes available for attack (for
example, arachidonic acid (AA) has three chemically equivalent
pentadienes), and a primary determinant of regiospecificity is
which pentadiene in the double bond system aligns with the
LOX catalytic iron (16). 2) The substrate can enter the active
site either carboxyl (“head”) or hydrocarbon (“tail”) first (2, 17).
This determines which side of the selected pentadiene is acces-
sible to the catalytic iron. In addition to the mode of fatty acid
binding, the direction of oxygen attack across the face of the
pentadiene determines the R or S chirality of the products (18).
As an example, 8R and 12S products have the hydroperoxide
moiety on the same side of the carbon chain and the 8S/12R-
hydroperoxides are on the opposite side. Taken together, the
fatty acid binding issues and direction of the reaction with O2
can “on paper” explain all the observed LOX-catalyzed specific
oxygenations of AA.
Although clues to LOX-substrate recognition have emerged
from a wealth of mechanistic chemistry, enzyme mutagenesis,
inhibitor structure-activity relationships, and crystal structures
of inhibitor complexes, what is missing is a melding of protein
structural information with a detailed picture of substrate
binding. The fundamental deterrent has been the difficulty in
obtaining the crystal structure of an enzyme-substrate com-
plex. Acting against the attempted crystallization of the
enzyme-substrate complex are (i) LOX enzymes require no
cofactor for the dioxygenase reaction and are therefore primed
for instant activity, (ii) the ready oxidation of the resting state
* This work was supported in part by National Institutes of Health Grants HL
R01 107887 (to M. E. N.) and GM 15431 (to A. R. B.) and in its early stages by
National Science Foundation Grant MCB-0818387.
The atomic coordinates and structure factors (code 4QWT) have been deposited
in the Protein Data Bank (http://wwpdb.org/).
1 To whom correspondence should be addressed: Dept. of Biological Sci-
ences, Louisiana State University, Baton Rouge, LA 70803. Tel.: 225-578-
738; Fax: 225-578-7258; E-mail: newcomer@lsu.edu.
2 The abbreviations used are: LOX, lipoxygenase(s); AA, arachidonic acid;
HETE, hydroxyeicosatetraenoic acid.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 289, NO. 45, pp. 31905–31913, November 14, 2014
Published in the U.S.A.
NOVEMBER 14, 2014 • VOLUME 289 • NUMBER 45 JOURNAL OF BIOLOGICAL CHEMISTRY 31905
This is an open access article under the CC BY license.
ferrous iron to the active ferric state by traces of peroxide, and
(iii) the O2 co-substrate is ubiquitous under standard condi-
tions of crystallography. Therefore, a combination of these fac-
tors has thwarted attempts to halt the one-turnover transfor-
mation that will metabolize a substrate molecule in the LOX
active site. Crystals of an 8R-LOX from Plexaura homomalla,
which generates 8R-hydroperoxyeicosatetraenoic acid from
AA, proved to be to sufficiently robust to survive the manipu-
lations required to introduce the hydrophobic substrate at con-
centrations of AA and carrier that do not compromise diffrac-
tion quality, but are adequate for complex formation.
Combined with the previously reported structures of the
mammalian lipoxygenases with inhibitors, the model provides
a robust framework for the design of isoform-specific inhibi-
tors. Furthermore, mutagenesis and activity assays support the
proposed model.
MATERIALS AND METHODS
Mutagenesis—Mutants were constructed in pseudo-wild-
type 8R-LOX (1) by whole plasmid polymerase chain reaction
using Pfu UltraII Hot Start polymerase (Agilent Technologies).
Where possible, silent mutations were included in the primers
for rapid identification of mutant plasmids. Plasmid DNA was
purified using the Wizard system (Promega).
Protein Expression and Purification—Pseudo-wild-type 8R-LOX
(19) and variants were expressed and purified essentially as
described in the literature with the following modifications
(11). BL21(DE3) cells were transformed with the appropriate
pet3a construct. Single colonies were picked to grow overnight
starter cultures in Luria Broth, 50 g/ml ampicillin. The starter
culture was then diluted 100 into 2 Yeast Tryptone and
grown at 37 °C to an A600 of 0.6, at which point the temperature
was changed to 22 °C, and expression was induced with 0.25
mM isopropyl 1-thio--D-galactopyranoside. The cells were
harvested after 22 h, frozen in liquid nitrogen, and stored at
80 °C. The frozen cells were resuspended in B-PER bacterial
protein extraction reagent (Thermo Scientific) supplemented
with DnaseI, PMSF, leupeptin, and pepstatin, according to the
manufacturer’s instructions, and sonicated at 5-s intervals and
50% power for 5 min. The cell lysate was centrifuged at
38,000  g for 30 min at 4 °C. The supernatant was cleared with
a 0.45-m Millipore PES syringe filter, and applied on a Co-
nitrilotriacetic acid column using AKTA FPLC. The 8R-LOX
was eluted using a gradient of 20 mM to 200 mM imidazole in 20
mM Tris (pH 8.0) and 500 mM NaCl. The fractions containing
the prominent peak of the absorbance chromatogram were
pooled and dialyzed against 20 mM Tris (pH 8.0) overnight with
three buffer exchanges. The dialyzed protein was then purified
further using a Mono-Q column and AKTA FPLC and a salt
gradient of 0 to 500 mM NaCl. Most of 8R-LOX eluted at 250
mM NaCl. The purities of fractions were evaluated by SDS-
PAGE and Coomassie staining; the fractions containing purest
8R-LOX were collected and concentrated to 5–15 mg/ml using
Amicon Ultra centrifugal units.
Kinetic Assays—The kinetic measurements were performed
on an Applied Photophysics Stopped Flow instrument
SX.18MV, monitoring the increase in absorbance at 237 nm
over time in the following buffer: 50 mM Tris (pH 7.4), 150 mM
NaCl, 0.5 mM EDTA. The concentration of enzyme was 15
(native), 20 (R182A), or 200 nm (A589M and A620H). For each
enzyme at least 10 AA (Cayman Chemical) concentrations,
varying from 1–50 M, were monitored. Initial rates were mea-
sured by fitting the average of four to five measurements of the
initial linear region of absorbance change to a linear equation.
Most of the variants were analyzed by using the Michaelis-
Menten equation to determine Vmax and Km values; however,
the R182A mutant was analyzed by using the reciprocal plot












Equation 1 has been used before to study other systems that
involve cooperative substrate inhibition, and it was the model
that gave the best fit to the experimental data (20 –22). An
extinction coefficient of 23 absorbance units/cm/mM (23) was
used for product.
FIGURE 1. Schematic of the current model for product specificity in lipoxygenases. Cavity depth and substrate orientation combine to confer regio- and
stereo- specificity. The substrate (AA shown here) must align between the catalytic iron (red sphere) and O2 channel (blue peanut). Differences in cavity depth
and head-to-tail orientation determine the hydroperoxyeicosatetraenoic acid generated.
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Product Analyses—Incubations were carried out in 1 ml of 50
mM Tris, pH 8.0, containing 500 mM NaCl, 2 mM CaCl2, using
50 M arachidonic acid (15 g) added in 5 l of ethanol. (10-ml
incubations were carried out with the slowly reacting A589M
and A620H mutants.) The samples were incubated at room
temperature for 2–10 min, with the time depending on the rate
of reaction observed by UV-235 nm. The incubations were
extracted using a Waters 1-cc Oasis HLB cartridge and eluted
with 1 ml of methanol. The extracts were treated with triphe-
nylphosphine in methanol at room temperature for 30 min to
reduce hydroperoxyeicosatetraenoic acid to the corresponding
hydroxtetraenoic acid (HETE). The samples were analyzed (and
the individual HETEs collected) by SP-HPLC using a Beckman
Ultrasphere 5 silica column (250  4.6 mm) with a solvent sys-
tem of hexane/isopropanol/glacial acetic acid (100:2:0.1, by vol-
ume) running at 1 ml/min, and the eluant was monitored with an
Agilent 1100 diode array detector. The individual HETEs were
then methylated with diazomethane, and the stereochemistry of
the 8-, 11-, 12-, and 15-HETE products was determined using a
Chiralpak AD column (250  4.6 mm) with a solvent of hexane/
methanol (100:2, v/v) running at 1 ml/min (24).
Crystallization—Crystals of 8R-LOX were prepared in an
anaerobic chamber maintained below 20 ppm O2. Crystals were
grown by vapor diffusion with a well solution of 8% PEG-8000,
5% glycerol, 0.2 M CaCl2, 0.1 M imidazole acetate, pH 8.0. Crys-
tals were then soaked overnight (17 h) in a solution of 25%
glycerol, 10% PEG-8000, 0.02 M CaCl2, 0.1 M imidazole acetate,
pH 8.0, 1% dimethyl sulfoxide, and 1 mg/ml AA. The next
morning, crystals were cooled in liquid nitrogen that was
brought into the anaerobic chamber. During the cooling pro-
cess, O2 levels rose to 55 ppm (due to O2 dissolved in the liquid
nitrogen).
Structure Determination—Diffraction data from the soaked
8R-LOX crystals were collected with an ADSC Quantum 315 at
the NE-CAT 24ID-E beamline located at the Advanced Photon
Source. Two data sets were collected from a single crystal. The
data were indexed, integrated, and scaled with XDS (25),
merged with XSCALE, and analyzed with POINTLESS (26) and
AIMLESS (27).
The structure of 8R-LOX (3FG1) described previously was
used as the starting model for refinement. Iterative model
building and refinement were run in PHENIX (28) and COOT
(29). Four monomers are located in the asymmetric unit. Resi-
dues for the N-terminal His tag were modeled only where suf-
ficient electron density warranted (one N-terminal His for
chains A, B, and D and three N-terminal His for chain C). In
addition, residues 307–315 were not modeled in any of the
chains, along with residue 316 in chain A, residues 305 and 306
in chain B, and residue 306 in chain D, due to lack of electron
density in those regions. Residue 600 was not modeled in chain
B, also due to a lack of electron density. Arachidonate was mod-
eled into electron density present in the active site of chain C.
An omit map, calculated after three cycles of coordinate refine-
ment of the model without AA, shows clear density for the
substrate (Fig. 2C). Electron density in the active sites of the
other monomers was suggestive of AA, but insufficient to
model the ligand structure in these sites with confidence. The
final Rfactor/Rfree was 16.21/21.45%. Data processing and refine-
ment statistics are provided in Table 1. Although the AA B-fac-
tor (39 Å2) is higher than the average protein B-factor (29 Å2), it
is within the range of those of the neighboring amino acid side
chains (21 to 46 Å2). The coordinate and structure factors have
been deposited to the Protein Data Bank and assigned the iden-
tifier 4QWT.
RESULTS
Invariant Amino Acids Position the Pentadiene for Attack—
The crystal structure 8R-LOX was determined to 2.0 Å resolu-
tion. Lipoxygenases are composed of an amino-terminal -barrel
domain and a largely -helical catalytic domain, which is 80% of
the polypeptide (6) and harbors the catalytic iron. Those enzymes
that metabolize AA are roughly 650 amino acids in length.
Although in general the placement of elements of secondary struc-
ture in lipoxygenases is conserved, helix 2, which helps define the
active site, has been observed in two strikingly distinct orienta-
tions: it can be a long single -helix that runs the length of the
catalytic domain or a broken helix in which some side chains are
inserted into the common active site to conceal it from bulk sol-
vent. Helix 2 is one long helix in 8R-LOX and substrate can enter
without invoking a major conformational change.
The catalytic iron in 8R-LOX is positioned by three invariant
His (384, 389, 570) side chains and the terminal main chain
TABLE 1
Data collections and refinement statistics




Resolution range (Å) 50–2.0 (2.11–2.0)
Space group P21
Unit cell
a, b, c (Å) 104.0, 170.6, 104.7
B (°) 95.4
Total reflections 914,097 (129,971)
Unique reflections 242,473 (34,734)
Multiplicity 3.8 (3.7)
Completeness (%) 99.5 (96.1)














RMS (bonds) (Å) 0.007









a Rmerge  hkl j Ihkl, j 	 Ihkl	/hkl j Ihkl	.
b Rmeas  hkl nhklnhkl 	 1 j  1n Ihkl, j 	 Ihkl	/hkl j Ihkl	.
c Rp.i.m.  hkl 1nhkl 	 1 j  1n Ihkl, j 	 Ihkl	/hkl j Ihkl	.
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carboxylate of an invariant Ile (693). A large U-shaped cavity, in
which Fe2 sits at the base of the U, is observed in the structure
of 8R-LOX in the absence of substrate (30). An arched helix,
kinked by a distinct two-amino acid insertion in one helical turn
(first described in detail by Minor et al. (31)), covers this site and
contributes one of several invariant leucines that line the pro-
posed substrate binding pocket.
In the structure of 8R-LOX with AA bound (Fig. 2, A and B)
this “arched” helix (420 – 442) is displaced ever-so-slightly out-
wards (C-C distance 
 1.3 Å for Ile-437) and the side chains
of Leu-431 and Ile-437, which frame the insertion, are now
ordered (Fig. 2, A and B). These amino acids make van der
Waals contacts to secure the AA, Leu-431 with the central car-
bon of the pentadiene centered at C10. Ile-437 is positioned at
the top of the “U” between the carboxyl head (C1) and C17 at
the tail. These amino acids side chains fill the U from the side
opposite of the catalytic iron, where just across from Leu-431
sits invariant Leu-627. Leu-627 and Leu-431 are equidistant
from the substrate, and the two side chains appear to clamp the
C10 pentadiene in place. The base of the U is positioned by
invariant Leu-385 on one side, and the iron and His-384 and
His-389 on the other. Leu-385 and the catalytic iron cradle the
base of the U (Fig. 2C).
Pocket depth, which allows the tail to slide in so that C10 is
attacked, appears to be conferred by Ala-620, which with Ala-
589 makes for a very a deep cavity. Leu-381 and Val-428 define
the wall of the cavity at C15, and the polar and charged amino
acids Gln-380 and Asp-424 (highly conserved) flank the cluster
of histidines that hold the iron in place. In the absence of AA,
Tyr-181 and Arg-182 of helix 2 participate in an interhelical
charge cluster with Glu-430 of the arched helix. In the AA-
bound structure, the AA carboxylate expands this charge net-
work with only the slight shift in the arched helix described
above and the reorientation of the side chain of Glu-430 to
allow Arg-182 to interact with the substrate carboxylate as well
as Glu-430.
FIGURE 2. 8R-LOX with AA. A, ribbon drawings of 8R-LOX with (blue) and without (gray) AA in the active site. Fe2 is shown as a red sphere. The helical insertion
described in all LOX structures is shown in violet. B, detail of the outward shift of the arched helix observed in the presence of AA. C, an omit map contoured
2/2 (green/magenta) reveals clear electron density for AA. D, the steady state rate dependence on substrate concentration of 8R-LOX and the mutant
R182A. 8R-LOX data were fit to the Michaelis-Menten equation, whereas the R182A data were fit to Equation 1. Equation 1 describes cooperative substrate
inhibition for the fit, n 
 2.4  0.3.
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Apparent in the crystal structure is a tubular opening that
leads to the U-shaped site. It sits on the face of the AA opposite
the Fe and is thus positioned to allow molecular oxygen to
access the pentadiene. This tubular cavity abuts the shallower
side of the U, where C8 of AA sits. Proximal to the substrate it is
defined by Gly-427. Access to the pentadiene from the iron side
is blocked not only by the residues that position the iron but
also by Ile-427, which is invariant.
Thus, the substrate-binding site is formed largely by invari-
ant amino acids, and these amino acids are positioned around
the pentadiene that is adjacent to the catalytic iron. The depth
of the cavity is set by residues 620 and 589, and the cavity
entrance is defined by amino acids from 2.
Mutations to the Binding Site Affect Enzyme Activity and
Product Specificity—Site-directed mutants were prepared to
test the structural interpretation. Arg-182, which appears to
charge pair with the substrate carboxylate, was mutated to Ala.
Ala-589 and Ala-620, positioned deep in the cavity to allow the
AA tail slide into the enzyme active site to position C10 at the
catalytic site, were mutated to methionine and histidine,
respectively, to introduce bulk and charge at the putative
hydrocarbon end of the active site. Whereas the mutation of
R182A had only a modest impact on product specificity (Table
2), the kinetic properties of the enzyme were dramatically
different from that of the wild type enzyme, as this mutant
displayed striking substrate inhibition (Fig. 2D). In contrast,
mutations deep in the cavity lead to 11R-hydroperoxy-
eicosatetraenoic acid as the primary product, a product consis-
tent with a shallower site. To generate the 11R-product, C13,
rather than C10, must be at the catalytic center.
The steady state kinetic parameters for wild type 8R-LOX
and the single amino acid substitution variants are shown in
Table 2. The kcat for A620H is 2% of that for 8R-LOX, whereas
the kcat for A589M is reduced to 15%.
The R182A mutant displays conspicuous substrate inhibi-
tion for the reaction with AA. The rate versus substrate concen-
tration plots of R182A and the wild type are shown in Fig. 2D,
along with the curve fit for Michaelis-Menten and substrate
inhibition kinetics. Prior to fitting the data to the substrate inhi-
bition model, the Km of R182A was first determined by the
double reciprocal plot of 1/
o versus 1/[S] as described (32) and
fitting a linear line to the data at intermediate substrate concen-
trations. The Km determined from the double reciprocal plot
was then used as a constant in fitting the substrate inhibition
curve using Equation 1.
DISCUSSION
Cavity Depth as a Determinant of Product Formation—The
LOX reaction proceeds with the abstraction of hydrogen from
the sp3 carbon of a pentadiene via a water molecule that fills the
metal coordination sphere. The resulting free radical is delocal-
ized along the pentadiene, and oxygenation occurs at the car-
bon 2 from the site of attack. Hydrogen abstraction and oxy-
genation occur on opposite faces of the substrate, and the
structural basis for this relationship is clearly elucidated in the
structure of 8R-LOX with AA. The substrate fills a U-shaped
cavity, and at the base of the U, the catalytic iron is positioned
by the side chains of conserved amino acids. Of the 16 amino
acids that define this cavity and make contacts with the AA six
are invariant: two His (384, 389) that also bind the iron, three
Leu (385, 431, 627), and an Ile (627). All of these amino acids are
positioned to envelope the pentadiene centered at C10 for
attack. AA enters 8R-LOX tail first and slides deep into the
active site, which is exceptionally deep when compared with
that described for other LOX structures due to an Ala at posi-
tion 620 as compared with Met, His, Val, or Gln in other LOX
structures (Table 3). Consistent with tail first entry, the deepest
part of the binding site is formed by hydrophobic amino acids
(Fig. 3A). Moreover, the mutation of A589M, deep in the cavity,
gives 11R-HETE, indicating attack at C13, rather than C10, as
expected for a shallower cavity with tail-first entry of AA (Fig. 1
and Table 2). The introduction of a histidine at position 620 not
only shortens the deepest part of the U-shaped cavity, but adds
a positive charge, making it challenging for the substrate to bind
in a tail-first orientation. As a result, the Km increases, and the
turnover rate plummets. Similar to A589M, the major product
TABLE 2
The impact of 8R-LOX mutations on the enzyme product profile and kinetic parameters
ND indicates not determined. Major products are underlined, and tail-first entry stereo-chemistry is indicated with boldface type.
Enzyme/Product % of products % R:S Km kcat kcat/Km Fold change Ki
M s1 M
8R-LOX
8-HETE 97.9 99:1 30  7 210  23 6.9  1.7 1
12-HETE 2.1 ND
R182A
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is 11R-HETE along with minor amounts of predominantly 12S-
and 15S-HETES, all consistent with a shallower tail-first entry
into the active site (Table 2).
The Importance of Substrate Tethering—Whereas cavity
depth determines how deep the AA slides into the active site,
our data suggest that van der Waals contacts alone (the steric
complementarity of the AA and the U-shaped active site) are
not sufficient to adequately fix the geometry of the pentadiene
at the catalytic iron in 8R-LOX. The long hydrocarbon tail of
the substrate makes extensive contacts with the amino acid side
chains lining the site, but helix 2 must provide a polar/charged
amino acids to interact with the AA carboxyl group, perhaps to
prevent AA from penetrating deeper into the cavity, which
extends beyond C20 of the AA. Although substitution of Arg-
182 with Ala has only a modest effect on the Km for AA or the
product generated, the mutant displays dramatic substrate
inhibition. Substrate inhibition in LOX has been reported pre-
viously (for example, Refs. 33 and 34), but it was unexpected
that a single substitution of R182A would have such a large
impact on enzyme activity. However, substrate inhibition by a
compound with few hydrogen bond donors/acceptors for pre-
cise positioning can be explained by a non-productive binding
mode that makes many of the same substrate-protein contacts
observed in the productive binding mode. The AA, untethered
by the polar/charge contact with the carboxylate, is not posi-
tioned precisely at the catalytic center.
Substrate inhibition has been studied in other enzymes (20,
35–37), and its analysis can be complex (32, 38, 39). We
observed that the R182A data are best explained by cooperative
substrate inhibition (Equation 1). In this case, the cooperativity
observed may be due to an untethered hydrophobic substrate
that can assume multiple non-productive conformations in
the hydrophobic cavity and be retained there without having
to reenter the aqueous milieu before positioning itself into
an alternate conformation. Thus, we suggest that Arg-182
securely positions the substrate in a catalytically competent
orientation at the active site machinery. The modest loss of
product specificity (88 versus 98% 8-HETE), is consistent
with this interpretation.
Can Cavity Depth Be Predicted?—The obvious question,
given the structural similarity observed in the LOX family, is
whether this 8R-active site is consistent with the other enzyme
structures that have been reported. There are now structures
for six AA-metabolizing LOX. In addition to the 8R-LOX, an
11R-, a 5S-, two 15S- (15-LOX-1 and 15-LOX-2), and 12S-
lipoxygenases have been described (7, 9, 12, 40, 41). With the
TABLE 3
The amino acids that define the AA binding site in 8R-LOX and their counterparts in other LOX structures
Overall sequence identity with P. homomalla 8R-LOX is indicated in parentheses. The two far right columns include the highly homologous 15-LOX-1 and 12-LOX pair.
Residues in bold are invariant.
8R-LOX 11R-LOX (47%) 5-LOX (38%) 15-LOX-2 (33%) 15-LOX-1 (30%) 12-LOX (30%)
4QWTa 3FG1a 3O8Ya 4NREa 2P0Ma 3RDEa
Tyr-178 Phe-185 Phe-177 Phe-184 Phe-175 Phe-175
Arg-182 Gly-188 Tyr-181 Ala-188 Leu-179 Leu-179
Gln-380 Gln-369 Gln-363 Glu-369 Gln-357 Glu-357
His-384 373 367 373 361 361
Leu-385 374 368 374 362 362
His-389 378 372 378 366 366
Ile-423 412 406 412 400 400
Gly-427 Gly-416 Ala-410 Ala-416 Ala-404 Ala-404
Leu-431 420 414 420 408 408
Ile-437 Ala-426 Leu-420 Val-426 Ile-414 Ile-414
Val-438 Ala-427 Phe-421 Val-427 Phe-415 Phe-415
Leu-442 Leu-431 Asn-425 Thr-431 Met-419 Leu-419
Ala-589 Thr-575 Pro-569 Pro-572 Cys-560 Cys-560
Ala-620 Met-606 His-600 Val-603 Gln-590 Gln-590
Thr-623 Val-609 Ala-603 Ala-606 Ile-593 Ile-593
Ile-626 Ala-612 Ala-606 Leu-609 Gln-596 Gln-596
Leu-627 613 607 610 597 597
a Protein Data Bank codes.
FIGURE 3. The AA-binding site. A, the substrate adopts a horseshoe shape in the U-shaped channel (stereo). The side chains of highly conserved amino acids
line the base of the active site, along with Gly-427. Glu-430, part of an inter-helical charge cluster that includes the substrate carboxylate, is shown in line
rendering. The Fe2 (transparent dark red sphere) is positioned behind the substrate. B, detail of the superposition of inhibitors (rotated 180° with respect to
A) observed in 15-LOX-2 (red) 12-LOX (gold, C; red, O) and 15-LOX-1 (teal, C; red, O). The 15-LOX-2 and 12-LOX inhibitors conform to the AA placement, whereas
the 15-LOX-1 inhibitor overlaps partially. The Fe2, solid dark red sphere, is in front of the substrate.
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exception of the 15-LOX-1/12-LOX pair, which share 79%
sequence identity, pairwise identity for these enzymes is at most
47%. It is the 8R-/11R pair that has 47% sequence identity, and
in terms of cavity depth, the most significant difference is pres-
ence of a Met in the latter enzyme, instead of Ala-620 (Table 3).
The Met protrudes directly in U-shaped cavity and limits its
depth so that C13 is positioned for attack in the 11R enzyme.
For the 15-LOX-2 enzyme, which also must position C13 at the
catalytic machinery, the back end of the cavity is shortened by
Val-610 and a Leu at 607.
However, this simple relationship between amino acid side
chain volume deepest in the U and cavity depth is not straight-
forward as overall sequence identity decreases. For instance,
both porcine 12-LOX and 8R-LOX (30% identity) are tail first
enzymes that position C10 at the catalytic center; thus, they
should have similar cavity depths. Yet 12-LOX has a Gln at the
deepest part of the cavity (Ala-620 in 8R-LOX). Unlike the Met
side chain in 11R-, the Gln lies perpendicular to the tail end of
the cavity, resulting in cavity depth comparable with that in
8R-LOX.
Further complicating comparisons among these structures is
the fact that porcine 12-LOX and rabbit 15-LOX-1 share 80%
identity and have only one conservative difference in the amino
acids that line the U-shaped site (Table 3, Met/Leu-419). Yet in
the rabbit enzyme, the AA can only slide deep enough to posi-
tion C13, rather than C10 at the catalytic iron. One significant
conformational difference in this highly homologous pair is a
conspicuous constriction conferred by Phe-415 (Val-438 in
8R-LOX) and Leu-597 in 15-LOX-1. Whereas the amino acids
are present in the 12-LOX, and Leu-597 is invariant, placement
of the latter in 15-LOX-1 is anomalous with respect to the other
LOX structures in Table 3.
Substrate- and Inhibitor-induced Conformational Changes—
8R-LOX is the only LOX for which structures are available in
the absence and presence of substrate; only modest conforma-
tional changes are necessary to accommodate the AA. Yet this
is clearly not the case for all family members, as in 5-LOX and
11R-LOX the cavities are “corked,” and the active site is con-
cealed from bulk solvent. Inhibited structures have been
reported for rabbit 15-LOX-1 (2P0MB), human 15-LOX-2
(Protein Data Bank code 4NRE), and porcine 12-LOX (Protein
Data Bank code 3RDE). The 8R-pocket agrees well with those
defined for the inhibited 15-LOX-2 and 12-LOX structures.
However, 15-LOX-1 shows a dramatic reorientation of 2 in
the presence of the inhibitor RS7. Although the cavity must be
reconfigured for the substrate to enter to position the C13 pen-
tadiene because of the constriction described above, whether it
requires displacement of 2 is not clear. The RS7 conformation
may be unique to the inhibitor, which is constrained in a con-
formation inconsistent with the U-shaped site (Fig. 3B).
An O2 Access Pathway—Also common to the LOX structures
is the long tubular opening that emanates from the cavity at the
base of the U, from the side opposite the catalytic iron (31). In
the 8R-enzyme, this channel extends to the surface and reveals
a likely path for O2 to access the activated pentadiene. In each of
the reported structures, a similar “channel” is observed. Work
by Knapp et al. (42) demonstrated the importance of the coun-
terpart of 8R-LOX Leu-431, positioned proximal to the inter-
section of the channel and the catalytic site, in controlling
access to the activated pentadiene for soybean LOX-1.
Subsequently, Coffa and Brash (18) reported a Gly/Ala
switch in LOX that directs the stereochemistry of the product.
8R- and 11R-enzymes have a Gly at this residue, whereas the
12S-, 15S-, and 5S-enzymes all have an alanine. One way to
think about this “switch” is that it directs O2 to the carbon that
is either 2 or 2 from the central carbon of the pentadiene.
The 8R-, 11R-, 15S-, and 12S-LOX are all tail-first enzymes, and
for the R enzymes, the oxygen channel is tilted “above” the iron
to allow access to the more shallow C-2 carbon. For the S
enzymes, the channel is nudged toward the deeper C 2 carbon
(Fig. 4). Note that Gly-427 (and its counterparts) defines the top
of the putative O2 channel where it abuts the U-shaped cavity.
The presence of Ala shields this position and molds the channel
deeper into the cavity, so that O2 no longer has access to C-2.
Placement of the shielding invariant Leu (8R-LOX Leu-431),
one turn of the helix from the Gly/Ala switch, is coupled to the
switch.
Concluding Remarks—Over the years, individual LOX struc-
tures have led to models for substrate recognition by this
enzyme family. The “boot-shaped” model was derived from the
inhibited 15-LOX structure and suggested that Ile-418, Phe-
353, and Ile-593 define cavity depth and that Arg-403 tethered
the substrate carboxylate (43). Of these four amino acids, two
are included in Table 3. Although the boot-shaped model nicely
explained the supporting mutagenesis data, in retrospect, it was
incomplete due to what was then interpreted as disordering of
FIGURE 4. The antarafacial relationship between Fe2 and a putative O2
access channel. A, in 8R-LOX the direction of the channel is set by Gly-427
and the orientation of the shielding amino acid Leu-431. B and C, similar
channels in 15-LOX-2 and 12-LOX. Note the presence of an Ala pushes the
tubular opening deeper into the body of the enzyme. D, detail of the relation-
ship between the Gly/Ala switch and the Leu-431 shielding residues. Note the
absence of the side chain in the 8R-enzyme (blue) and positioning of Leu-431
leave C8 (C-2) of the AA unprotected. Blue, 8R-LOX; green, 15-LOX-2; beige,
12-LOX. In contrast, in the 15-LOX-2 and 12-LOX enzymes, the same carbon
would be shielded by the Ala and the invariant Leu no longer shields C12
(C2) at the opposite end of the pentadiene.
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helix 2 (10, 40). Additionally, it was based on an inhibitor that
lacks the structural flexibility of AA and so might include con-
formational changes not required for the natural substrate to
enter. Subsequently, a U-shaped model was described (30),
which included 60% of the amino acids in Table 3; this model
was flawed as well, as it set the direction of the tail of AA more
in the direction of the O2 channel. Eek et al. (7), tested both
these models with the 11R structure, and the data are consistent
with our 8R-LOX-AA structure. However, 11R-LOX is corked
in the absence of substrate so the complete U shape could not
be described in that enzyme either. The structure of 8R-LOX
with substrate builds on these models to reveal a robust struc-
tural context for mechanistic studies that have provided tre-
mendous insight into how similar enzymes can generate dis-
tinct products from a common substrate. It is clear that subtle
structural differences among family members are not readily
inferred with sequence information alone, and the design of
isoform-specific inhibitors that might lead to the development
of novel therapeutics remains a challenge.
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28. Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols,
N., Headd, J. J., Hung, L. W., Kapral, G. J., Grosse-Kunstleve, R. W., Mc-
Coy, A. J., Moriarty, N. W., Oeffner, R., Read, R. J., Richardson, D. C.,
Richardson, J. S., Terwilliger, T. C., and Zwart, P. H. (2010) PHENIX: a
comprehensive Python-based system for macromolecular structure solu-
tion. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221
29. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molec-
ular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126 –2132
30. Neau, D. B., Gilbert, N. C., Bartlett, S. G., Boeglin, W., Brash, A. R., and
Newcomer, M. E. (2009) The 1.85 A structure of an 8R-lipoxygenase sug-
gests a general model for lipoxygenase product specificity. Biochemistry
48, 7906 –7915
31. Minor, W., Steczko, J., Stec, B., Otwinowski, Z., Bolin, J. T., Walter, R., and
Axelrod, B. (1996) Crystal structure of soybean lipoxygenase L-1 at 1.4 A
resolution. Biochemistry 35, 10687–10701
32. Lineweaver, H., and Burk, D. (1934) The determination of enzyme disso-
ciation constants. J. Am. Chem. Soc. 56, 658 – 666
33. Peng, S., and van der Donk, W. A. (2003) An unusual isotope effect on
The Enzyme-Substrate Complex of 8R-Lipoxygenase
31912 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289 • NUMBER 45 • NOVEMBER 14, 2014
substrate inhibition in the oxidation of arachidonic acid by lipoxygenase.
J. Am. Chem. Soc. 125, 8988 – 8989
34. Berry, H., Debat, H., and Larreta-Garde, V. (1997) Excess substrate inhi-
bition of soybean lipoxygenase-1 is mainly oxygen-dependent. FEBS Lett.
408, 324 –326
35. Chen, C., Joo, J. C., Brown, G., Stolnikova, E., Halavaty, A. S.,
Savchenko, A., Anderson, W. F., and Yakunin, A. F. (2014) Structure-
based mutational studies of substrate inhibition of betaine aldehyde
dehydrogenase BetB from Staphylococcus aureus. Appl. Environ. Mi-
crobiol. 80, 3992– 4002
36. Szegletes, T., Mallender, W. D., Thomas, P. J., and Rosenberry, T. L. (1999)
Substrate binding to the peripheral site of acetylcholinesterase initiates
enzymatic catalysis: substrate inhibition arises as a secondary effect. Bio-
chemistry 38, 122–133
37. Ziegler, J., Brandt, W., Geissler, R., and Facchini, P. J. (2009) Removal of
substrate inhibition and increase in maximal velocity in the short chain
dehydrogenase/reductase salutaridine reductase involved in morphine
biosynthesis. J. Biol. Chem. 284, 26758 –26767
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